{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:52:38Z","timestamp":1760921558052},"reference-count":100,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.2217\/imt-2017-0026","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T14:31:15Z","timestamp":1501770675000},"page":"767-780","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Overcoming Barriers of car T-cell Therapy in Patients with Mesothelin-Expressing Cancers"],"prefix":"10.1080","volume":"9","author":[{"given":"Mark H","family":"O\u2019Hara","sequence":"first","affiliation":[{"name":"Department of Hematologic Oncology of the University of Pennsylvania,The University of Pennsylvania Health System,\r3400 Spruce street,\rPhiladelphia,\rPA\r19104,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Stashwick","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology,Lancaster General Hospital,\r555 N Duke street,\rLancaster,\rPA\r17602,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Plesa","sequence":"additional","affiliation":[{"name":"Department of Pathology &amp; Laboratory Medicine of The University of Pennsylvania,The University of Pennsylvania Health System,\r3400 Spruce street,\rPhiladelphia,\rPA\r19104,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janos L","family":"Tanyi","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology of the University of Pennsylvania,The University of Pennsylvania Health System,\r3400 Spruce street,\rPhiladelphia,\rPA\r19104,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32446"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"e_1_3_2_5_1","first-page":"18","volume-title":"American Association for Cancer Research Annual Meeting","author":"Alley EW","year":"2015","unstructured":"Alley EW , MolifeRL, SantoroAet al. Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma. Presented at:American Association for Cancer Research Annual Meeting. Philadelphia, PA, USA, 18\u201322April2015."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3397"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa3643"},{"key":"e_1_3_2_10_1","first-page":"18","volume-title":"American Association for Cancer Research Annual Meeting","author":"Tanyi J","year":"2015","unstructured":"Tanyi J , HaasA, BeattyGet al. Safety and feasibility of chimeric antigen receptor modified T cells directed against mesothelin (CART-meso) in patients with mesothelin-expressing cancers. Presented at:American Association for Cancer Research Annual Meeting. Philadelphia, PA, USA, 18\u201322April2015."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215134"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504542"},{"key":"e_1_3_2_13_1","volume-title":"ASCO Annual Meeting 2015","author":"Schuster SJ","year":"2015","unstructured":"Schuster SJ , SvobodaJ, NastaSet al. Phase IIa trial of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed or refractory CD19+ lymphomas. Presented at:ASCO Annual Meeting 2015. Chicago, IL, USA, 29 May\u20132 June 2015."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000154"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.03.006"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2016.06.010"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1001-957"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(00)00343-4"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.05.015"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac5415"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103849"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.0225"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500308"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.1.136"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.3672"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312372200"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.8.2902-2906.2000"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2614"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1862"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0993"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114900"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep01870"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20110282"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604964"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1662"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.9738\/INTSURG-D-13-00001.1"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3429"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3077-5"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040157"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2012.02214.x"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200311000-00003"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1309\/F1B64CL7H8VJKEAF"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pai.00000141545.36485.d6"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000056981.16578.C3"},{"key":"e_1_3_2_45_1","first-page":"3","volume-title":"The American Society of Clinical Oncology Annual Meeting","author":"Tanyi J","year":"2016","unstructured":"Tanyi J , HaasA, BeattyGet al. Anti-mesothelin chimeric antigen receptor T cells in patients with epithelial ovarian cancer. Presented at:The American Society of Clinical Oncology Annual Meeting. Chicago, IL, USA, 3\u20137June2016."},{"issue":"11","key":"e_1_3_2_46_1","first-page":"3520","article-title":"Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro","volume":"8","author":"Hassan R","year":"2002","unstructured":"Hassan R , LernerMR, BenbrookDet al. Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro. Clin. Cancer Res.8(11), 3520\u20133526 (2002).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep09928"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0006"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.83"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215175"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.4.F9"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/46218"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.12.003"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076514"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002842"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0095"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1310"},{"issue":"9","key":"e_1_3_2_58_1","first-page":"3689","article-title":"Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte\/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2\/neutolerized mice","volume":"61","author":"Machiels JP","year":"2001","unstructured":"Machiels JP , ReillyRT, EmensLAet al. Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte\/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2\/neutolerized mice. Cancer Res.61(9), 3689\u20133697 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000715)87:2<253::AID-IJC17>3.0.CO;2-A"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1348"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.240"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199607000-00006"},{"issue":"5","key":"e_1_3_2_63_1","first-page":"2572","article-title":"Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide","volume":"46","author":"Berd D","year":"1986","unstructured":"Berd D , MaguireHCJr, MastrangeloMJ. Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res.46(5), 2572\u20132577 (1986).","journal-title":"Cancer Res."},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.5449"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1209"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4523"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348540"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0202-143"},{"key":"e_1_3_2_69_1","first-page":"149","article-title":"Adoptive cellular therapy","volume":"344","author":"Grupp SA","year":"2010","unstructured":"Grupp SA , JuneCH. Adoptive cellular therapy. Curr. Top. Microbiol. Immunol.344, 149\u201372 (2010).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46110"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.09.004"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3838"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0170"},{"key":"e_1_3_2_74_1","article-title":"Safety and antitumor activity of chimeric antigen receptor modified T cells in patients with chemotherapy refractory metastatic pancreatic cancer","volume":"33","author":"Beatty GL","year":"2015","unstructured":"Beatty GL , O\u2019HaraMH, NelsonAMet al. Safety and antitumor activity of chimeric antigen receptor modified T cells in patients with chemotherapy refractory metastatic pancreatic cancer. ASCO Meeting Abstracts33, Abstract 3007 (2015).","journal-title":"ASCO Meeting Abstracts"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2627"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0458"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1300"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1860"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6204"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010162"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0405"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2133"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6442"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.03.017"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2233"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.04.025"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320318110"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.09.028"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0351"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0263"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3833"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1699"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0153"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3050"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0869"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0062"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.31"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0460-x"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1159\/000338179"},{"issue":"9","key":"e_1_3_2_102_1","first-page":"2120","article-title":"Etanercept in the treatment of macrophage activation syndrome","volume":"28","author":"Prahalad S","year":"2001","unstructured":"Prahalad S , BoveKE, DickensD, LovellDJ, GromAA. Etanercept in the treatment of macrophage activation syndrome. J. Rheumatol.28(9), 2120\u20132124 (2001).","journal-title":"J. Rheumatol."}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2017-0026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T20:29:47Z","timestamp":1715977787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2017-0026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.2217\/imt-2017-0026"],"URL":"https:\/\/doi.org\/10.2217\/imt-2017-0026","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-08-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}